Summit Therapeutics SMMT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's operating lease ROU assets?
- Summit Therapeutics (SMMT) reported operating lease ROU assets of $19.4M in Q1 2026.
- How has Summit Therapeutics's operating lease ROU assets changed year-over-year?
- Summit Therapeutics's operating lease ROU assets increased by 205.4% year-over-year, from $6.35M to $19.4M.
- What is the long-term trend for Summit Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease ROU assets has grown at a 106.1% compound annual growth rate (CAGR), from $554K to $20.62M.
- What does operating lease ROU assets mean?
- The value of the right to use leased property over the term of the lease.
- How do you interpret operating lease ROU assets?
- An increase indicates the expansion of leased facilities or longer lease terms.
- How does operating lease ROU assets compare across companies?
- Standardized across all companies following the adoption of ASC 842 lease accounting.